Medical News

RSS

Local health clinics in U.S. do not offer diabetes screening, obesity prevention programs to poor clients: Study

A new nationwide study finds that some local health clinics do not offer diabetes screening or obesity prevention programs to their clients, who tend to be poor. The clinics need to be "armed and equipped" to respond to the growing threat from type 2 diabetes and obesity in the United States, said researcher and study co-author Ann Albright. "These are huge problems that we're facing. We want to be sure that we're responding effectively."

23 Jun 2010

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the publication of data from a mouse model of diet-induced obesity in the June, 2010 edition of the journal Endocrinology. The data showed that mice treated with XOMA 052 both prophylactically and therapeutically experienced improvement in measures associated with diabetes and cardiovascular disease including reduction in glycosylated hemoglobin levels, improvement in glucose control, improved beta-cell survival and function, and a reduction in total cholesterol without reduction in high density lipoprotein.

23 Jun 2010

Insuring your health: Rising costs spur increase in health savings accounts

In this Kaiser Health News consumer column, Michelle Andrews writes: "High-deductible health plans and the health savings accounts (HSAs) that link to them are becoming a familiar fixture on the insurance landscape, even though they get mixed reviews from many consumers and health-policy experts" (Andrews, 6/22).

23 Jun 2010

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

23 Jun 2010

Medicare physician payment cuts could cost millions more in reprocessing

Politico reports that the fight over a "doc fix" — fixing the Medicare reimbursement rate for doctors — is "straining not just doctors but also House-Senate relations" and could cost taxpayers millions of dollars. "Having waited for weeks in hopes of a stay, the Centers for Medicare & Medicaid Services, or CMS, is now enforcing a 21 percent cut in physician payments, and an estimated 50 million claims, held back since June 1, will be the first affected."

23 Jun 2010

IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor

ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.

23 Jun 2010

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

Researchers at the University of Rochester Medical Center have discovered yet another reason to filter the foreign white cells from donor blood: The resulting blood product is associated with dramatically fewer cardiopulmonary complications for patients who received a transfusion.

23 Jun 2010

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.

23 Jun 2010

HHS, insurers, health systems preparing for health law's impact

Politico reports on the Department of Health and Human Services' HealthCare.gov, "the new Web portal that goes live July 1 and is designed to give consumers a place to research and compare health insurance plans. Since it will be the most tangible link to the health reform law for many Americans, health policy experts and administration officials say it's crucial that the site is well-designed, easy to navigate and free of the jargon that makes the field of health insurance so unintelligible to the public. ... When HealthCare.gov launches next Thursday, it will have information about insurance plans that users can sort based on their own situation and their eligibility for public insurance programs, like Medicare, the Children's Health Insurance Program and the new high-risk pools for individuals with pre-existing conditions" (Kliff, 6/22).

23 Jun 2010

Psychotropic medications associated with pediatric ADRs in Denmark: Researchers

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than half of these were serious and several were birth defects - suggesting that tighter controls on the prescription of psychotropic medications to pregnant women may be required.

23 Jun 2010

Senate Dems explore phase-out of Medicaid enhanced funding

Congressional Quarterly: Senate Democrats are negotiating with "a pair of pivotal Republicans" a slimmed-down version of the tax bill that they were unable to clear last week. "The most significant change being discussed would shrink the cost of a $24.2 billion provision that extends extra federal Medicaid funds to struggling states."

23 Jun 2010

Weikang Bio-Technology files for listing on NASDAQ

Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company had filed an application to list its common stock on the NASDAQ Capital Market.

23 Jun 2010

Exposure to chlordecone associated to increased risk of prostate cancer: Researchers

In an article to be published on 21 June 2010 in the Journal of Clinical Oncology, researchers from Inserm (Inserm unit 625 - Research Group on Human and Mammalian Reproduction, University of Rennes 1), the CHU (University Hospital Centre) in Pointe - Pitre (urology department, University of the French West Indies and Guiana) and from the Center for Analytical Research and Technology (University of Li-ge, Belgique), show that exposure to chlordecone (also named Kepone), an organochlorine chemical with well defined estrogenic properties used in the French West Indies until 1993, is associated to a significant increased risk of prostate cancer.

23 Jun 2010

FDA approves Hospira's meropenem for injection, USP (I.V.)

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.

23 Jun 2010

AIDS specialist leaves Calif. practice, citing rising costs

A long-time San Francisco AIDS specialist is closing his clinic and moving to Manhattan because of frustration with the insurance industry and the rising cost of practicing medicine, the San Francisco Chronicle reports. "The bottom line is, you cannot make a living practicing medicine unless you work at least 50 to 60 hours a week," said Dr. Marcus Conant, one of the first AIDS doctors in the area. "I'm not the only doctor who's getting to the point where it's not worth it."

23 Jun 2010

Health reform includes changes to denied claims, health savings accounts

News outlets examine some changes to the health care system that health reform will bring, including help for those with denied insurance claims and health savings account modifications.

23 Jun 2010

iCAD image analysis software program used in DCE-MRI studies demonstrated at ASCO 2010

ACR Image MetrixTM, an imaging contract research organization with expertise in imaging trial design, techniques and data extraction, in conjunction with its software partner, iCAD, gave demonstrations of the iCAD image analysis software program used in DCE-MRI studies at the ACR Image Metrix booth during the 2010 Annual American Society of Clinical Oncology Meeting, which took place June 4-8, 2010, in Chicago, IL.

23 Jun 2010

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a six-month Priority Review.

23 Jun 2010

No increased risk of childhood cancer if born near mobile phone stations: Study

There have been concerns regarding increased risk for cancer in children born to mothers who lived near mobile phone stations during their pregnancy after a report of a cluster of childhood cancer cases near such stations. A newly published study in the British Medical Journal refutes such beliefs and has found no link to early childhood cancers and living near mobile phone masts.

22 Jun 2010

Cancer forms “intolerable burden” on the community: Health Minister

A new report reveals that here has been a 10 percent rise in cancer figures from 2006 in Australia. The figure translates to nearly 115,000 Australian cancer cases and 43,700 Australians are expected to die from the disease this year.

22 Jun 2010

Medical News

Local health clinics in U.S. do not offer diabetes screening, obesity prevention programs to poor clients: Study

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Insuring your health: Rising costs spur increase in health savings accounts

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Medicare physician payment cuts could cost millions more in reprocessing

IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

HHS, insurers, health systems preparing for health law's impact

Psychotropic medications associated with pediatric ADRs in Denmark: Researchers

Senate Dems explore phase-out of Medicaid enhanced funding

Weikang Bio-Technology files for listing on NASDAQ

Exposure to chlordecone associated to increased risk of prostate cancer: Researchers

FDA approves Hospira's meropenem for injection, USP (I.V.)

AIDS specialist leaves Calif. practice, citing rising costs

Health reform includes changes to denied claims, health savings accounts

iCAD image analysis software program used in DCE-MRI studies demonstrated at ASCO 2010

Genentech's Lucentis for treatment of macular edema following RVO receives FDA approval

No increased risk of childhood cancer if born near mobile phone stations: Study

Cancer forms “intolerable burden” on the community: Health Minister

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News